drugset / Trial / NCT03133650
A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus Who Have Trouble Swallowing
Phase 1
Active not recruiting
12 enrolled
Memorial Sloan Kettering Cancer Center
Steba Biotech S.A. · collabWeizmann Institute of Science · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to establish the highest dose of laser light for WST-11 VTP to treat obstruction from esophageal cancer that can be safely given.
Timeline
- Start
- 2017-04-26
- Primary completion
- 2027-02-23
- Completion
- 2027-02-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Padeliporfin | Other / unclassified | 4 mg/kg | Intravenous |